Clinical Trial Update: 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients [NA]

View source ↗

Summary

This clinical trial update discusses the use of two gallium-68 PET tracers, 68Ga-P16-093 and 68Ga-PSMA-11, in the same group of patients with primary prostate c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-P16-093 (P16-093 Ga-68 radiopharmaceutical)
• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer | NA | Status: RECRUITING